Cargando…
Relapsing Babesiosis With Molecular Evidence of Resistance to Certain Antimicrobials Commonly Used to Treat Babesia microti Infections
Human babesiosis cases are emerging with an increased incidence and a wider geographic range worldwide. Relapsing babesiosis cases are becoming more frequently encountered in clinical practice associated with the use of immunosuppressive medications. The 2020 Infectious Diseases Society of America b...
Autores principales: | Marcos, Luis A, Wormser, Gary P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394720/ https://www.ncbi.nlm.nih.gov/pubmed/37539067 http://dx.doi.org/10.1093/ofid/ofad391 |
Ejemplares similares
-
First Report of Babesia microti-Caused Babesiosis in Spain
por: Arsuaga, Marta, et al.
Publicado: (2016) -
Use of tafenoquine to treat a patient with relapsing babesiosis with clinical and molecular evidence of resistance to azithromycin and atovaquone
por: Marcos, Luis A., et al.
Publicado: (2022) -
Histopathological Analysis of Selected Organs of Rats with Congenital Babesiosis Caused by Babesia microti
por: Jasik, Krzysztof, et al.
Publicado: (2023) -
Babesia and Human Babesiosis
por: Montero, Estrella, et al.
Publicado: (2022) -
Vertical Transmission of Babesia microti, United States
por: Joseph, Julie T., et al.
Publicado: (2012)